The rapid rise of medical weight loss treatments is driving major shifts in aesthetic patient behavior, with more consumers seeking facial volume restoration and other cosmetic procedures as they lose weight, according to new data released Wednesday by Allergan Aesthetics, an AbbVie company. 

The company reported that 67% of patients undergoing medical weight loss now say their goals have shifted toward improving appearance, not just losing weight.

Nearly half (47%) of medical weight loss patients were reported by clinicians to benefit most from hyaluronic acid injectable fillers to address post‑weight‑loss volume loss, which Allergan said has emerged as a leading concern among patients using GLP‑1 medications.

“Allergan Aesthetics is committed to equipping our customers with data‑driven insights, education and consultation tools to help guide patients safely and effectively through these changes,” said Glen Curran, senior vice president at Allergan Aesthetics.

He said new patients entering the aesthetic market are seeking individualized, long‑term treatment options focused on restoring balance and volume in the face. Forty percent of medical weight loss patients are reportedly considering professionally administered aesthetic treatments.

Aesthetic providers are increasingly the point of entry for MWL patients: 60% of GLP‑1 users now receive their medications from providers who also offer aesthetic treatments, an increase from 49% in late 2024. 

The findings suggest that aesthetic providers may see higher demand for injectables, skin treatments and long‑term consultation as more Americans use GLP‑1 medications. Early consultation and treatment planning can help patients navigate rapid facial changes linked to weight reduction. 

The reported data comes from proprietary consumer market research, physician collaboration, and data shared at leading medical forums, such as that presented at the 2025 American Society for Dermatologic Surgery (ASDS) Annual Meeting and published in January 2026 in the Aesthetic Surgery Journal's Open Forum, "Nonsurgical Aesthetic Treatment of the Face and Neck in GLP-1 Receptor Agonist Weight Loss Patients: Experience-Based Considerations," which demonstrated that patients are increasingly seeking physician-guided aesthetic solutions to address changes in facial appearance following weight loss.

Download the MWL & Aesthetics infographic from Allergan Aesthetics to learn more.